This question has been answered by the relevant Government Department.
Question text
Lord Mendelsohn to ask Her Majesty's Government why patients who are immunocompromised must (1) test positive for COVID-19, (2) have no detectable antibodies for COVID-19, and (3) have been hospitalised specifically for acute symptoms of COVID-19, in order to access Ronapreve; and what plans they have to end this health inequality between immunocompromised patients and the rest of the population. HL4093
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.
Date Answered
Wednesday 1 December 2021
Member's Registered Interests
There are no interests to show.
Main Member
Lord Mendelsohn
Labour
Life peer